(NASDAQ: PLUR) Pluri's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 27.23%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,656.83%.
Pluri's earnings in 2026 is -$26,138,000.On average, 3 Wall Street analysts forecast PLUR's earnings for 2026 to be -$27,679,746, with the lowest PLUR earnings forecast at -$26,594,266, and the highest PLUR earnings forecast at -$28,493,856.
In 2027, PLUR is forecast to generate -$19,478,340 in earnings, with the lowest earnings forecast at -$18,714,483 and the highest earnings forecast at -$20,051,232.